The technology provides urologists with real-time ultrasound imaging, magnetic resonance imaging and 3D-visualized biopsy data while navigating the cancerous tumor, according to a July 10 press release from Cottage Health.
The combination of these technologies allows for precise targeting and removal of the cancerous area, enabling a smaller portion of the prostate to be ablated without making incisions. Removing a smaller portion of tissue minimizes the damage to the surrounding healthy tissue and the risk of negative side effects, according to the release.
